Advisor Group Holdings, Inc. Exelixis, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 19,315 shares of EXEL stock, worth $711,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,315

Previous 16,387 17.87%

Holding current value

$711,757

Previous $425,000 51.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$25.39 - $36.46 $74,341 - $106,754	2,928 Added 17.87%	19,315 $643,000
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $966 - $1,214	-44 Reduced 0.27%	16,387 $425,000
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $520,297 - $607,013	-25,580 Reduced 60.89%	16,431 $369,000
Q1 2024 May 10, 2024	SELL	$20.17 - $23.93 $1.17 Million - $1.38 Million	-57,778 Reduced 57.9%	42,011 $996,000
Q4 2023 Feb 12, 2024	SELL	$19.25 - $24.13 $763,262 - $956,754	-39,650 Reduced 28.44%	99,789 $2.39 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $401,782 - $479,859	21,102 Added 17.83%	139,439 $3.05 Million
Q2 2023 Aug 10, 2023	SELL	$18.17 - $20.48 $159,932 - $180,264	-8,802 Reduced 6.92%	118,337 $2.26 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $530,923 - $632,222	32,572 Added 34.44%	127,139 $2.47 Million
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $21,213 - $24,659	-1,418 Reduced 1.48%	94,567 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $203,808 - $289,465	-12,998 Reduced 11.93%	95,985 $1.5 Million
Q2 2022 Aug 10, 2022	BUY	$17.44 - $23.16 $228,115 - $302,932	13,080 Added 13.64%	108,983 $2.27 Million
Q1 2022 May 04, 2022	BUY	$17.03 - $22.67 $572,378 - $761,938	33,610 Added 53.95%	95,903 $1.89 Million
Q3 2021 Nov 05, 2021	BUY	$16.3 - $21.14 $38,109 - $49,425	2,338 Added 3.9%	62,293 $1.32 Million
Q2 2021 Aug 02, 2021	BUY	$17.95 - $25.56 $34,679 - $49,381	1,932 Added 3.33%	59,955 $1.1 Million
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $89,654 - $110,135	-4,367 Reduced 7.0%	58,023 $1.32 Million
Q4 2020 Feb 10, 2021	BUY	$18.39 - $24.8 $14,987 - $20,212	815 Added 1.32%	62,390 $1.25 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $67,508 - $87,986	-3,266 Reduced 5.04%	61,575 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $592,000 - $986,187	-35,966 Reduced 35.68%	64,841 $1.54 Million
Q1 2020 May 18, 2020	BUY	$14.46 - $21.8 $1.46 Million - $2.2 Million	100,807 New	100,807 $1.74 Million

Others Institutions Holding EXEL

# of Institutions

564

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Exelixis, Inc. Transaction History